Foto del docente

Walter Cabri

Full Professor

Department of Chemistry "Giacomo Ciamician"

Academic discipline: CHIM/06 Organic Chemistry

Publications

vai alle Pubblicazioni

Publications prior to 2004

One Book: “From Bench to Market. The Evolution of Chemical Synthesis from Discovery to Industrial Production.”; Oxford University Press: Oxford, 2000.

103 patents/patents applications: https://worldwide.espacenet.com/searchResults?ST=singleline&locale=en_EP&submitted=true&DB=&query=walter+cabri&Submit=Search

118 Pubblications 

118. “Pharmaceutical green chemistry in peptide synthesis A snapshot on the role of solvents in SPPS” Martelli,G.; Ferrazzano,L.; Tolomelli,A.; Ricci,A.; Cabri,W. Chemistry Today 2020,38,14.

117. “Boosting basic-peptide separation through dynamic electrostatic-repulsion reversed-phase (d-ERRP) liquid chromatography”Mazzoccanti,G.; Manetto,S. Bassan,M.; Foschini,A.; Orlandin,A.; Ricci,A.; Cabri,W.; Ismail,O.H.; Catani,M.; Cavazzini,A.; Gasparrini,F.      RSC Adv., 2020,10,12604.

116. "Overcoming chemical challenges in the solid-phase synthesis of high-purity GnRH antagonist Degarelix. Part 2” Guryanov, I.; Orlandin, A.; Viola, A.; Biondi,B.;Formaggio,F.;Ricci,A.;Cabri, W. OPRD 2020,2,274

115. “Modeling the nonlinear behavior of a bioactive peptide in reversed-phase gradient elution chromatography” De Luca,C. ; Felletti,S. ; Macis,M. ; Cabri,W. ; Lievore,G. ; Chenet,T. ; Pasti,L. ; Morbidelli,M. ; Cavazzini,C. ; Catani,M. ; Ricci,A. Journal of Chromatography A 2020,1616,460789.

114. “Natural Occurring and Engineered Enzymes for Peptide Ligation and Cyclization” imo,N.;Ana,T.;Schmidt,M.;Ricci,A.; Cabri.W. Frontier in Chemistry 2019,7,829

113. "Overcoming chemical challenges in the solid-phase synthesis of high-purity GnRH antagonist Degarelix" Guryanov,I.;Orlandin,A.;Viola,A.;Biondi,B.;Badocco,D.;Formaggio,F.; Ricci,A.; Cabri,W. OPRD 2019,23, 2746.

112. “Novel insights into the chemistry of an old medicine: a general degradative pathway for penicillins from a piperacillin/tazobactam stability study.” Viola,A.; Ferrazzano,L: Martelli,G.; Cerisoli,L.; Ricci,A.; Tolomelli,A.;Cabri.W. Eur.J.Pharm.Sci. 2019,14,10495.

111. “Green Solvents Mixtures for Solid-Phase Peptide Synthesis (GM-SPPS). A DMF free high efficient synthesis of pharmaceutical grade peptides.” Ferrazzano.L.;Corbisiero,D.;Martelli,G.;Tolomelli,A.; Viola,A.; Ricci,A.; Cabri,W. ACS Sustainable Chemistry 2019,7,12867.

110. “Investigating the Neuroprotective Effects of Turmeric Extract: Structural Interactions of β-Amyloid Peptide with Single Curcuminoids” Randino,R.; Grimaldi,M.; Persico,M.; De Santis,A.; Cini,E.; Cabri,W.; Riva,A.; D’Errico,G.; Fattorusso,C.; D.Ursi,A.M.; Rodriquez,M. Sci.Rep. 2016,6,38846.

109.“Innovative chemical synthesis and conformational hints on the lipopeptide liraglutide.”Guryanov,I .; Bondesan,A.; Visentini,D.; Orlandin,A.; Biondi,B.;Toniolo,C.; Formaggio,F.; Ricci,A.; Zanon,J.; Cabri,W. J.Pept.Sci. 2016,22,471.

108. “Production of peptides as generic drugs: a patent landscape of octreotide.” Sabatino,G.; Guryanov,I.; Rombecchi,A.;Zanon,J.; Ricci,A.; Cabri,W.; Papini,A.M.; Rovero.P. Expert Opin Ther Pat 2016,26,485.

 107. “Fight Against Onchocerciasis/Lymphatic Filariaris And Malaria: Avermectin And Artemisinin, Lead Compounds from Nature.” Cabri,W. La Chimica e l’Industria 2016,98,48.

106.Recovery of bioactive compounds from artichoke brines by nanofiltration.” Cassano,A.; Cabri, W.; Mombelli,G.; Peterlongo,F.; Giorno,L. Food and Bioproducts Processing 2016,98,257.

105. “Hypoglycemic Effects of a Standardized Extract of Salvia miltiorrhiza Roots in Rats”. Carai,M.A.M.; Colombo,G.; Loi,B.; Zaru,A.; Riva,A.; Cabri,W.; Morazzoni,PPharmacognosy Magazine 2015,11,S545.

104. Potent, Metabolically Stable 2-Alkyl-8-(2H-1,2,3-triazol-2-yl)-9H-adenines as Adenosine A2A Receptor Ligands.” Pace,S.; Brogin,G.; Stasi,M.A.; Riccioni,T.; Borsini,F.; Capocasa,F.; Manera,F.; Tallarico,C.; Grossi,P.; Vacondio,F.; Bassi,M.; Bartoccini,F.; Lucarini,S.; Piersanti,G.; Tarzia,G.; Cabri,W.; Minetti,P. J.MedChem. 2015,10,1149.

103 Thermodynamic and kinetic investigation of monoketo-aldehyde-peroxyhemiacetal (MKA), a stereolabile degradation product of dihydroartemisinin” Kotoni,D.; Piras,M.; Cabri,W.; Giorgi,F.; Mazzanti,A.; Pierini,M.; Quaglia,M.; Villanoi,C.; Gasparrini,F.  RSC Adv., 2014,4,32847-32857

102. “ST7612AA1, a thioacetate-ω(γ-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitors. [http://www.ncbi.nlm.nih.gov/pubmed/25233084] ” Giannini,G.; Vesci,L.; Battistuzzi,G.; Vignola,D.; Milazzo,F.M.; Guglielmi,M.B.; Barbarino,M.; Santaniello,M.; Fantò,N.; Mor,M.; Rivara,S.; Pala,D.; Taddei,M.; Pisano,C.; Cabri.W. J.Med.Chem. 2014,57,8358.

101. “Biotransformation of Colchicinoids into Their Corresponding 3-O-Glucosyl Derivatives by Selected Strains of Bacillus megaterium. [http://www.ncbi.nlm.nih.gov/pubmed/24553816] ” Ponzone,C.; Berlanda,D.; Donzelli,F.; Acquati,V.; Ciulla,R.; Negrini,A.; Rovati,M.; Evangelista,D.; Fata,E.; Ciceri,D.; Perterlongo,F.; Cabri W. Mol.Biotechnol. 2014,56,653.

100. “4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors. 4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors.” Baruchello,R.;Simoni,D.;Marchetti,P.; Rondanin,R.;Mangiola,S.;Costantini,C.;Meli,M.; Giannini, G.;Vesci,L.;Carollo,V.; Brunetti,T.; Battistuzzi,G.; Tolomeo,M.; Cabri,W. Eur.J.Med.Chem. 2014,76,53.

99. “Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold.”  Taddei,M.; Ferrini,S.; Giannotti,L.; Corsi,M.; Manetti,F.; Giannini,G.; Vesci,L.; Milazzo,F.M.; Alloatti,D.; Guglielmi,M.B.; Castorina,M.; Cervoni,M.L.; Barbarino,M.; Foderà,R.; Carollo,V.; Pisano,C.; Armaroli,S.; Cabri,W.  J.Med.Chem. 2014, 57, 2258.

Latest news

At the moment no news are available.